Frontlight ResearchEarly access
Trial site
Beacon Hospital
- 4running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Head and neck cancer1 trial
- Metastatic breast cancer1 trial
- Phase
- Phase 32 trials
- Phase 21 trial
- Phase 2/31 trial
- Status
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Completed1 trial
- Suspended1 trial
- Lead sponsor
- National Cancer Centre, Singapore2 trials
- Bayer1 trial
- Celcuity Inc1 trial
- Inhibrx Biosciences, Inc1 trial
- Pfizer1 trial
Running trials
Recruiting
Recruiting
Recruiting
Ordastobart (INBRX-106) Add-on to Pembrolizumab in 1L HPV+ PD-L1+ R/M OPSCC (HexAgon-HN)
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026